PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.\', \'Dutch Medicines Evaluation Board, Utrecht, The Netherlands.\', \'Committee for Medicinal Products for Human Use, European Medicines Agency (EMA), Amsterdam, The Netherlands.\', \'Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.\', \'European Medicines Agency (EMA), Amsterdam, The Netherlands.\', \'Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands p.mol@cbg-meb.nl.\', \'Scientific Advice Working Party, European Medicines Agency (EMA), Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00817310.1136/bmjgh-2021-008173
?:hasPublicationType
?:journal
  • BMJ global health
is ?:pmid of
?:pmid
?:pmid
  • 35304352
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Attention for sex in COVID-19 trials: a review of regulatory dossiers.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35304352>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35304352>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all